• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症与血管生成中的环氧化酶-2

Cyclooxygenase-2 in cancer and angiogenesis.

作者信息

Sahin Mehmet, Sahin Emel, Gümüslü Saadet

机构信息

Department of Biochemistry, Faculty of Medicine, Akdeniz University, Antalya, Turkey.

出版信息

Angiology. 2009 Apr-May;60(2):242-53. doi: 10.1177/0003319708318378. Epub 2008 May 27.

DOI:10.1177/0003319708318378
PMID:18505747
Abstract

Tumor angiogenesis is a process where new blood vessels are formed from preexisting ones, resulting in several pathologies. Solid tumors induce angiogenesis to obtain the required nutrients and oxygen. Otherwise, tumors do not grow beyond 2 to 3 mm in diameter. Cyclooxygenase-2, an inducible enzyme important in inflammation, catalyzes the production of prostanoids from arachidonic acid. Cyclooxygenase-2 plays an important role in several cancer types, including colorectal, gastric, prostate, breast, lung, and endometrial cancer. Besides, cyclooxygenase-2 has been implicated in the progression and angiogenesis of cancers. Cyclooxygenase-2 inhibitors have been used to block angiogenesis and tumor proliferation. In this review, the recent studies related to the role of cyclooxygenase-2 in several cancer types and tumor-induced angiogenesis were compiled.

摘要

肿瘤血管生成是一个从已有的血管形成新血管的过程,会导致多种病变。实体瘤诱导血管生成以获取所需的营养和氧气。否则,肿瘤直径不会超过2至3毫米。环氧化酶-2是一种在炎症中起重要作用的诱导酶,催化花生四烯酸生成前列腺素。环氧化酶-2在多种癌症类型中发挥重要作用,包括结直肠癌、胃癌、前列腺癌、乳腺癌、肺癌和子宫内膜癌。此外,环氧化酶-2与癌症的进展和血管生成有关。环氧化酶-2抑制剂已被用于阻断血管生成和肿瘤增殖。在本综述中,汇编了与环氧化酶-2在多种癌症类型和肿瘤诱导的血管生成中的作用相关的最新研究。

相似文献

1
Cyclooxygenase-2 in cancer and angiogenesis.癌症与血管生成中的环氧化酶-2
Angiology. 2009 Apr-May;60(2):242-53. doi: 10.1177/0003319708318378. Epub 2008 May 27.
2
Cyclooxygenase inhibition in early onset of tumor growth and related angiogenesis evaluated in EP1 and EP3 knockout tumor-bearing mice.在携带肿瘤的EP1和EP3基因敲除小鼠中评估环氧化酶抑制对肿瘤生长早期发作及相关血管生成的影响。
Angiogenesis. 2005;8(4):339-48. doi: 10.1007/s10456-005-9023-8. Epub 2006 Jan 7.
3
Heparanase promotes angiogenesis through Cox-2 and HIF1alpha.乙酰肝素酶通过环氧化酶-2(Cox-2)和缺氧诱导因子1α(HIF1α)促进血管生成。
Med Hypotheses. 2007;68(1):162-5. doi: 10.1016/j.mehy.2006.03.055. Epub 2006 Aug 4.
4
A mathematical model of tumour angiogenesis, regulated by vascular endothelial growth factor and the angiopoietins.一种由血管内皮生长因子和血管生成素调节的肿瘤血管生成数学模型。
J Theor Biol. 2004 Aug 21;229(4):435-54. doi: 10.1016/j.jtbi.2004.04.012.
5
Tumor angiogenesis.肿瘤血管生成
J Med Assoc Thai. 1999 Apr;82(4):394-404.
6
Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration.癌症、肿瘤血管生成与内皮细胞迁移中的缝隙连接蛋白和Roundabout蛋白
Angiogenesis. 2008;11(1):13-21. doi: 10.1007/s10456-008-9100-x. Epub 2008 Feb 9.
7
Managing tumor angiogenesis: lessons from VEGF-resistant tumors and wounds.肿瘤血管生成的管理:来自VEGF抗性肿瘤和伤口的经验教训。
Adv Cancer Res. 2009;103:25-42. doi: 10.1016/S0065-230X(09)03002-4.
8
The enigmatic role of angiopoietin-1 in tumor angiogenesis.血管生成素-1在肿瘤血管生成中的神秘作用。
Cell Res. 2003 Oct;13(5):309-17. doi: 10.1038/sj.cr.7290176.
9
Inhibition of angiogenesis by small-molecule antagonists of protease-activated receptor-1.蛋白酶激活受体-1小分子拮抗剂对血管生成的抑制作用
Semin Thromb Hemost. 2007 Oct;33(7):680-7. doi: 10.1055/s-2007-991535.
10
Pro-angiogenic cytokines and their role in tumor angiogenesis.促血管生成细胞因子及其在肿瘤血管生成中的作用。
Cancer Metastasis Rev. 2006 Sep;25(3):373-85. doi: 10.1007/s10555-006-9011-5.

引用本文的文献

1
Overexpression of COX-2 and clinicopathological features of gastric cancer: a meta-analysis.COX - 2过表达与胃癌的临床病理特征:一项荟萃分析
Transl Cancer Res. 2020 Apr;9(4):2200-2209. doi: 10.21037/tcr.2020.03.52.
2
Pooled analysis of the clinical benefit of cyclooxygenase-2 inhibitors combined with chemotherapy in advanced non-small cell lung cancer.环氧化酶-2抑制剂联合化疗在晚期非小细胞肺癌中的临床获益的汇总分析。
Transl Cancer Res. 2019 Aug;8(4):1258-1267. doi: 10.21037/tcr.2019.07.06.
3
Molecular docking analysis of C-phycocyanin with VEGFR2.
藻蓝蛋白与血管内皮生长因子受体2的分子对接分析
Bioinformation. 2020 Nov 30;16(11):869-877. doi: 10.6026/97320630016869. eCollection 2020.
4
Assessment of the correlation between oxidative stress and expression of , and in human aortic smooth muscle cells.评估氧化应激与人类主动脉平滑肌细胞中、和表达之间的相关性。
Arch Med Sci Atheroscler Dis. 2021 Sep 20;6:e158-e165. doi: 10.5114/amsad.2021.109255. eCollection 2021.
5
Integrative molecular characterization of pediatric spinal ependymoma: the UK Children's Cancer and Leukaemia Group study.儿童脊髓室管膜瘤的综合分子特征:英国儿童癌症与白血病研究组的研究
Neurooncol Adv. 2021 Mar 8;3(1):vdab043. doi: 10.1093/noajnl/vdab043. eCollection 2021 Jan-Dec.
6
Ferulic Acid Prevents Angiogenesis Through Cyclooxygenase-2 and Vascular Endothelial Growth Factor in the Chick Embryo Chorioallantoic Membrane Model.阿魏酸通过环氧合酶-2和血管内皮生长因子在鸡胚绒毛尿囊膜模型中抑制血管生成。
Turk J Pharm Sci. 2020 Aug;17(4):424-431. doi: 10.4274/tjps.galenos.2019.44712. Epub 2020 Aug 28.
7
Prognostic and Clinical Significance of Cyclooxygenase-2 Overexpression in Endometrial Cancer: A Meta-Analysis.环氧化酶-2在子宫内膜癌中过表达的预后及临床意义:一项荟萃分析
Front Oncol. 2020 Aug 6;10:1202. doi: 10.3389/fonc.2020.01202. eCollection 2020.
8
Prostaglandin E2 Reverses the Effects of DNA Methyltransferase Inhibitor and TGFB1 on the Conversion of Naive T Cells to iTregs.前列腺素E2可逆转DNA甲基转移酶抑制剂和转化生长因子β1对初始T细胞向诱导性调节性T细胞转化的影响。
Transfus Med Hemother. 2020 Jun;47(3):244-253. doi: 10.1159/000502582. Epub 2019 Sep 19.
9
Fenretinide reduces angiogenesis by downregulating CDH5, FOXM1 and eNOS genes and suppressing microRNA-10b.芬维 A 降低 CDH5、FOXM1 和 eNOS 基因的表达并抑制 microRNA-10b,从而减少血管生成。
Mol Biol Rep. 2020 Mar;47(3):1649-1658. doi: 10.1007/s11033-020-05252-6. Epub 2020 Jan 10.
10
Multiple functions of HuR in urinary tumors.HuR 在尿路上皮肿瘤中的多重功能。
J Cancer Res Clin Oncol. 2019 Jan;145(1):11-18. doi: 10.1007/s00432-018-2778-2. Epub 2018 Oct 28.